Tech Company M&A Transactions

Abide Therapeutics Acquisition

Abide Therapeutics was bought by Lundbeck. The transaction occurred on 5/7/2019. The transaction price was $400 million.

Transaction Overview

Company Name
Acquired By
Announced On
5/7/2019
Transaction Type
M&A
Amount
$400,000,000
M&A Terms
Under the terms of the agreement, Lundbeck may pay USD 250 million (approximately DKK 1.65 billion) upfront with a commitment to pay future development and sales milestones to the group of current owners of up to USD 150 million (approximately DKK 1 billion). This acquisition provides Lundbeck a novel discovery platform and a U.S.-based research hub.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 250
San Diego, CA 92121
USA
Email Address
Overview
Realizing the therapeutic potential of novel serine hydrolase inhibitors to yield drugs for treatment of diseases in areas of unmet medical need.
Profile
Abide Therapeutics LinkedIn Company Profile
Social Media
Abide Therapeutics Company Twitter Account
Company News
Abide Therapeutics News
Facebook
Abide Therapeutics on Facebook
YouTube
Abide Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alan Ezekowitz
  Alan Ezekowitz LinkedIn Profile  Alan Ezekowitz Twitter Account  Alan Ezekowitz News  Alan Ezekowitz on Facebook
Chief Financial Officer
Stan Blackburn
  Stan Blackburn LinkedIn Profile  Stan Blackburn Twitter Account  Stan Blackburn News  Stan Blackburn on Facebook
Chief Financial Officer
Sapna Srivastava
  Sapna Srivastava LinkedIn Profile  Sapna Srivastava Twitter Account  Sapna Srivastava News  Sapna Srivastava on Facebook
Chief Medical Officer
Chan Beals
  Chan Beals LinkedIn Profile  Chan Beals Twitter Account  Chan Beals News  Chan Beals on Facebook
VP - Operations
Julianne Hunt
  Julianne Hunt LinkedIn Profile  Julianne Hunt Twitter Account  Julianne Hunt News  Julianne Hunt on Facebook
VP - R & D
Gary O'Neill
  Gary O'Neill LinkedIn Profile  Gary O'Neill Twitter Account  Gary O'Neill News  Gary O'Neill on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/7/2019: Carta venture capital transaction
Next: 5/7/2019: Noom venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary